Updated NCE Content Outline
For NCE exams administered ON or AFTER 1/2/2024
SEE content areas are uniform at 25% each
I. Basic Sciences (20%)
A. Anatomy and physiology

  1. Cardiovascular
  2. Respiratory
  3. Central nervous system
  4. Musculoskeletal
  5. Endocrine
  6. Hepatic and renal
  7. Hematologic
  8. Gastrointestinal
  9. Immune
    B. Pathophysiology
  10. Cardiovascular
    a. Ischemic heart disease
    b. Valvular heart disease
    c. Congenital heart defects
    d. Cardiac conduction and rhythm abnormalities
    e. Cardiovascular and peripheral vascular abnormalities
    f. Infectious diseases
    g. Pericardial diseases
    h. Cardiomyopathy and heart failure
  11. Respiratory
    a. Obstructive diseases
    b. Restrictive diseases
    c. Infectious diseases
    d. Pulmonary vascular abnormalities
    e. Altered airway anatomy
  12. Central nervous system
    1
    a. Neurodegenerative diseases
    b. Myelin diseases
    c. Cerebrovascular diseases
    d. Neuropathies
    e. Psychiatric disorders
    f. Spinal cord disorders
    g. Intracranial tumor
    h. Congenital abnormalities (e.g., cerebral palsy)
    i. Seizure disorders
    j. Intracranial hypertension
    k. Thermoregulation
  13. Musculoskeletal
    a. Myopathies/metabolic abnormalities (e.g., malignant hyperthermia)
    b. Neuromuscular diseases
    c. Skeletal diseases
    d. Musculoskeletal disorders (genetic and acquired)
  14. Endocrine
    a. Thyroid and parathyroid disorders
    b. Pituitary disorders
    c. Adrenal disorders
    d. Pancreatic disorders (endocrine disorders)
    e. Other endocrine disorders (thymus-, hypothalamus-, androgen-
    ,
    and metabolic-related disorders)
  15. Hepatic
    a. Infectious diseases
    b. Biliary tract and bilirubin disorders
    c. Cirrhotic disorders
    d. Hepatovascular abnormalities
  16. Renal
    a. Intrinsic kidney disorders
    b. Acute kidney injury
    c. Chronic kidney disease
  17. Hematologic
    a. Anemias
    b. Hemoglobin disorders
    c. Coagulation disorders
  18. Gastrointestinal
    a. Esophageal disorders
    b. Gastric disorders
    c. Pancreatic disorders (exocrine disorders)
    d. Intestinal disorders
    e. Tumors/secreting lesions
    f. Malabsorption disorders
    2
  19. Immune
    a. Infectious disorders (e.g., HIV, AIDS)
    b. Hypersensitivity disorders (Type I-IV)
    c. Autoimmune diseases
  20. Other conditions
    a. Cancer
    b. Burns (inhalational, cutaneous)
    c. Trauma
    d. Substance use disorder (alcohol, nicotine, other)
    e. Sepsis
    C. Pharmacology
  21. General principles
    a. Pharmacodynamics
    b. Pharmacokinetics
    c. Pharmacology-related mathematics
  22. Inhalation anesthetics
  23. Intravenous anesthetics and antagonists
    a. Barbiturates
    b. Sedative/hypnotics (e.g., propofol, etomidate, ketamine,
    dexmedetomidine)
    c. Benzodiazepines and benzodiazepine antagonists
    d. Opioid agonists, agonist-antagonists, and antagonists
  24. Depolarizing and nondepolarizing neuromuscular relaxants and antagonists
  25. Local anesthetics
  26. Lipid emulsion
  27. Regional anesthesia adjuncts (neuraxial and peripheral)
  28. Anticholinergics/cholinergic agonists
  29. Non-opioid analgesics
  30. Cardiovascular medications
    a. Inotropes
    b. Phosphodiesterase inhibitors
    c. Cardiac glycosides (e.g., digitalis)
    d. Alpha- and beta-receptor agonists and antagonists
    e. Centrally acting alpha2-adrenergic agonists
    f. ACE inhibitors
    g. Angiotensin II receptor inhibitors
    h. Vasodilators
    i. Nitric oxide
    j. Antidysrhythmics
    k. Calcium channel blockers
  31. Bronchodilators
    3
  32. Psychopharmacologic therapy
    a. Antidepressants
    b. Antipsychotics
    c. Antiparkinsonian drugs
    d. Others
  33. Prostaglandins
  34. Histamine receptor antagonists
  35. Antiemetics
    a. 5-HT3 receptor antagonists
    b. Gastrointestinal prokinetic medications (metoclopramide)
    c. Antacids
    d. Other
  36. Insulin
  37. Hypoglycemics
  38. Diuretics
  39. Anticoagulants and antagonists
    a. Heparin and low-molecular-weight heparins
    b. Heparin reversal—protamine
    c. Antiplatelet medications
    d. Oral anticoagulants
    e. Oral anticoagulant reversal
    f. Thrombolytics
    g. Thrombin inhibitors
  40. Procoagulants (e.g., antifibrinolytics, DDAVP)
  41. Antimicrobials and antivirals
  42. Antiepileptics
  43. Lipid-lowering agents
  44. Herbal remedies and dietary supplements
  45. Minerals and electrolytes
  46. Dantrolene
  47. Steroids (e.g., dexamethasone, hydrocortisone)
  48. Tocolytics
  49. Uterotonics
  50. Intravenous dyes
  51. Cannabinoids
    D. Applied chemistry, biochemistry, physics, and mathematics
  52. Chemistry and biochemistry
    a. Aqueous solutions and concentrations
    b. Acids, bases, and salts
    c. Chemical reactions: oxidation, reduction, hydrolysis, and conjugation
    d. Metabolism
    4
    II. e. Cellular mechanisms of action
    f. Drug receptor interaction
  53. Physics
    a. Units of measurement
    b. Gases and gas laws
    c. Solubility, diffusion, and osmosis
    d. Pressure and fluid flow
    e. Electricity and electrical safety
    f. Vaporization and humidification
    g. Measurement of oxygen, carbon dioxide, and hydrogen ions
  54. Nonpharmacology-related mathematics
    Equipment, Instrumentation and Technology (20%)
    A. Anesthetic delivery systems
  55. High/low pressure gas sources
  56. Regulators/manifolds
  57. Flowmeters, valves, floats
  58. Vaporizers
  59. Proportioning systems
  60. Pressure failure safety devices
  61. Failsafe devices
  62. Ventilator
  63. Carbon dioxide absorbents
  64. Anesthetic circuits
    a. Rebreathing, circle system
    b. Nonrebreathing
    c. Modified nonrebreathing
  65. Pneumatic and electronic alarm devices
    B. Airway equipment
  66. Face masks
  67. Laryngoscope
    a. Rigid
    b. Video laryngoscope
    c. Optically enhanced scopes
  68. Flexible fiberoptic bronchoscope
  69. Endotracheal tube
  70. Endobronchial tube
    a. Double-lumen tubes
    5
    b. Bronchial blockers
  71. Airways
    a. Oral
    b. Nasal
  72. Tracheostomy tubes
  73. Supraglottic airways (e.g., LMA)
  74. Intubating supraglottic airways
  75. Jet ventilation
  76. Intubating stylets
  77. Cricothyrotomy (needle and surgical)
  78. Intubation aids (e.g., bougie, exchange catheter)
    C. Monitoring devices
  79. Central nervous system
    a. Evoked potential
    b. Intracranial pressure
    c. Modified EEG monitor
    d. Cerebral oximetry
  80. Cardiovascular
    a. Electrocardiogram (3-lead and 5-lead)
    b. Arterial pressure monitoring
    c. Noninvasive blood pressure monitoring
    d. Central venous pressure monitoring
    e. Pulmonary artery pressure monitoring/SvO2
    f. Hemodynamic monitoring
    g. Precordial/esophageal stethoscope
    h. Transesophageal echocardiogram
  81. Respiratory
    a. Capnography
    b. Airway gas analysis
    c. Pulse oximetry
    d. Airway pressure
    e. Blood gas analysis
  82. Others
    a. Peripheral nerve stimulator (qualitative and quantitative)
    b. Temperature monitoring
    c. Maternal/fetal monitoring
    D. Patient warming equipment
  83. Fluid/blood warmers
  84. Forced air warming devices
  85. Heat and moisture exchanger (HME)
    6
  86. Radiant warmers
    E. Infusion devices (e.g., rapid infusers)
    F. Imaging and imaging safety
  87. Ultrasound
  88. Fluoroscopy
  89. Radiography
    III. General Principles of Anesthesia (35%)
    A. Ethical considerations
  90. Autonomy, beneficence, nonmalfeasance
  91. Research ethics
    B. Legal issues
  92. Advance healthcare directives
  93. Informed consent
  94. Disclosure of errors/ injuries
  95. Legal doctrines
  96. Torts
  97. Scope of practice
  98. Standards of practice
  99. Billing
    C. Safety and wellness
  100. Provider substance abuse disorder
  101. Issues surrounding patient safety
  102. Impaired provider
  103. Wellness initiatives and peer assistance
    D. Preoperative assessment and preparation of patient
    E. Fluid volume assessment and management
  104. 2. 3. Fluid/blood component therapy replacement (including plasma expanders)
    Bloodless medicine (including blood salvage devices and hemodilution
    techniques)
    Goal-directed fluid management (crossover with equipment)
    7
  105. Massive transfusion protocol
  106. Thromboelastography
    F. Positioning
  107. Techniques
  108. Physiologic alterations
  109. Complications
    G. Utilization and interpretation of testing data
  110. 2. Lab tests (blood gases, activated clotting time)
    Diagnostic exams (including basic 12-lead ECG interpretation)
    H. Airway management
  111. Assessment
  112. Techniques, procedures, and devices
  113. Complications
  114. Difficult airway management (difficult airway algorithm)
    I. Local/regional anesthetics (technique, physiologic alterations, complications)
  115. Anatomy
  116. Infiltration
  117. Topical
  118. Neuraxial blocks
  119. Peripheral blocks
  120. Other blocks (airway, retrobulbar)
  121. Ultrasound and/or nerve stimulator guided concepts and techniques
  122. Management of complications (e.g., local anesthetic systemic toxicity)
    J. Light, moderate, and deep sedation (monitored anesthesia care)
    K. Total intravenous anesthesia
    L. Pain
  123. Pain theory (anatomy, physiology, pathology, and psychodynamics)
    a. Acute
    b. Chronic
  124. Pain management
    a. Acute
    b. Chronic
    8
    c. Multimodal pain therapy
    M. Enhanced recovery after surgery (ERAS)
    N. Hypotensive technique and risks
    O. Postanesthesia care/respiratory therapy
    P. Infection control
  125. 2. Provider (e.g., personal protective equipment, room air handling,
    ultraviolet sanitizers)
    Patient (e.g., aseptic technique, workstation cleanliness, needle safety)
    Q. Intraoperative fire safety
    IV. Anesthesia for Surgical Procedures and Special Populations (25%)
    A. Surgical and diagnostic anesthesia, including management of complications
  126. Intra-abdominal
    a. Hepatobiliary system
    b. Gastrointestinal tract procedures
    c. Endocrine organ procedures
    d. Renal/genitourinary
    e. Gynecologic procedures
    f. Peritoneal procedures (including hernia repair)
  127. Extrathoracic
    a. Breast
    b. Plastics and/or reconstructive
  128. Head
    a. Extracranial
    i. Otolaryngological
    ii. Ophthalmologic
    iii. Nasal
    iv. Craniofacial
    v. Plastics and/or reconstructive
    vi. Orthodontic/dental
    b. Intracranial
    i. Decompression (burr holes, ventriculoperitoneal shunt)
    ii. Space-occupying lesion
    9
    iii. Vascular
    iv. Transsphenoidal hypophysectomy
    v. Stereotactic procedures
  129. Cardiac anesthesia
    a. Open procedures (e.g., coronary artery bypass grafting)
    b. Minimally invasive procedures (e.g., transcatheter aortic valve
    replacement/implantation [TAVR/TAVI], left atrial appendage closure
    implant, mitral clips)
    c. Interventional cardiology (e.g., pacemakers, automated internal
    cardiac defibrillator devices, electrophysiology cases)
    d. Management of patients with cardiac devices (e.g., ventricular assist
    device, extracorporeal membrane oxygenation, intraarterial balloon
    pump)
  130. Noncardiac intrathoracic (including open and thoracoscopic approach)
    a. Diaphragm
    b. Endoscopic procedures (bronchoscopy, mediastinoscopy)
    c. Esophagus
    d. Lung
    e. Mediastinum
  131. Neck
    a. Larynx/trachea
    b. Lymph node biopsies
    c. Parathyroid/thyroid
    d. Neck tumors
  132. Neuroskeletal
    a. Cervical spine (anterior and posterior approach)
    b. Laminectomy/discectomy fusions at all levels
    c. Pain management procedures
    d. Other
  133. Orthopedic
    a. Arthroscopic procedures
    b. Closed reduction
    c. Fractures
    d. Total joint replacements/arthroplasty
    e. Procedures of the hand and foot
  134. Perineal and pelvic procedures
    a. Gynecologic
    b. Genitourinary
    c. Anal/rectal
  135. Vascular (open versus endovascular)
    a. Carotid
    b. Thoracic
    c. Abdominal (including renal)
    10
    d. Extremity
    i. Occlusive disease
    ii. Vascular access
    e. Thromboembolic prevention
    f. Surgical management of portal hypertension
  136. Non-operating-room anesthesia (NORA)
    a. Diagnostic imaging and radiology
    b. Electroconvulsive therapy
    c. Interventional radiology
    d. Radiation therapy
    e. Endoscopy
  137. Robotic/laparoscopic surgery
  138. Other surgical procedures
    a. Trauma
    b. Burns
    c. Organ transplants (including management of posttransplant
    patient for nontransplant surgery)
    d. Organ procurement
    e. Laser procedures
    B. Anesthesia for special populations
  139. Pediatrics
    a. Anatomy, physiology, and pathophysiology
    i. Normal
    ii. Prematurity
    iii. Congenital abnormalities
    b. Pharmacology
    c. Anesthesia techniques/procedures
    d. Management of complications
  140. Obstetrics
    a. Anatomy, physiology, and pathophysiology
    b. Pharmacology
    c. Anesthesia techniques/procedures
    d. High-risk parturients
    e Nonobstetric surgery in the parturient
    f. Management of complications (e.g., amniotic fluid embolism, HELLP
    syndrome)
    g. Postpartum hemorrhage
  141. Geriatrics
    a. Anatomy, physiology, and pathophysiology
    b. Pharmacology
    c. Anesthesia techniques/procedures
    11
    d. Management of complications (e.g., postoperative cognitive dysfunction)
  142. Obesity
    a. Anatomy, physiology, and pathophysiology
    b. Pharmacology
    c. Anesthesia techniques/procedures (including bariatric)
    d. Management of complications
  143. Substance use disorder population
    a. Medication-assisted therapy (MAT) (e.g., methadone, buprenorphine)
    b. Pharmacologic interactions (e.g., acute intoxication)
    c. Pain management
    d. Management of complications
  144. Immune compromised and oncology patients
    a. Pharmacology
    b. Anesthesia techniques/procedures
    c. Management
    12